ALBERTDAVDBSEAlbert David Ltd-$HighNeutral
Announced Tue, 12 May · 19:10 IST

Re-appointment of Cost Auditors for the F.Y. 2026-27

Ceo ResignedManagement Changes View source PDF

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-10.5%1-day move
₹790.00
prior close
₹730.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-1.9-2.3-2.1-10.5-8.6-10.1-9.2-10.4-10.6-8.8-8.3-11.2
Up moveDown movePending
AI summary

Albert David Ltd held its Board Meeting on May 12, 2026, announcing several key decisions. The company appointed Mr. Amit Mahla as new CEO (effective May 12, 2026), replacing Mr. Umesh Manohar Kunte who resigned as Managing Director & CEO in December 2025. For FY 2025-26, the company reported a net loss of Rs. 149.47 Lakhs compared to a profit of Rs. 1,720.08 Lakhs in FY 2024-25 — a significant decline. Revenue from operations stood at Rs. 33,359.81 Lakhs. The Board recommended a final dividend of Rs. 5 per share (50% on Rs. 10 face value), subject to shareholder approval at the 87th AGM on August 6, 2026. Cost Auditors M/s. S. Gupta & Co. and Internal Auditors M/s. PricewaterhouseCoopers Services LLP were reappointed for FY 2026-27. Statutory auditors issued an unmodified opinion.

Likely market impact

The company swung from profit to loss in FY 2026, raising concerns about operational performance. The appointment of a new CEO from pharma giants like Cipla and Sun Pharma could bring strategic turnaround. Positive dividend declaration may provide some support to shareholders despite the loss.